text
"['\n1. 요약재무정보\n요약 연결,별도재무정보는 한국채택국제회계기준(K-IFRS) 작성기준에 따라 작성되었습니다.(1) 요약 연결재무정보\xa0\n(단위:천원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 목\n제20기 반기\n제19기(2018년)\n제18기(2017년)\n[유동자산]\n41,257,831\n41,734,769\n28,022,224\nㆍ매출채권및기타채권\n15,962,493\n8,225,764\n3,724,634\nㆍ재고자산\n4,736,998\n3,213,944\n8,038,867\nㆍ기타 유동자산\n20,558,340\n30,295,061\n16,258,723\n[비유동자산]\n75,466,966\n65,372,475\n21,420,296\nㆍ장기매출채권 및 기타채권\n-\n122,374\n122,008\nㆍ유형자산\n3,404,727\n3,495,560\n13,824,214\nㆍ기타의 비유동자산\n72,062,239\n61,754,541\n7,474,074\n자산\xa0 총계\n116,724,797\n107,107,244\n49,442,520\n[유동부채]\n27,309,905\n29,169,409\n17,760,320\n[비유동부채]\n15,685,995\n4,690,185\n1,339,983\n부채\xa0 총계\n42,995,900\n33,859,594\n19,100,303\n[납입자본]\n26,154,493\n22,274,896\n15,110,923\n[기타자본구성요소]\n57,931,781\n152,608,102\n136,709,521\n[결손금]\n(12,440,917)\n(107,381,159)\n(121,478,227)\n[비지배지분]\n2,083,540\n5,745,811\n-\n자본\xa0 총계\n73,728,897\n73,247,650\n30,342,217\n종속기업 등 투자주식 평가방법\n지분법\n지분법\n지분법\n2019.01.01~06.30\n2018.01.01-12.31\n2017.01.01~12.31\n매출액\n42,648,332\n47,375,134\n26,832,432\n계속영업이익(손실)\n(291,081)\n(8,756,238)\n(15,937,902)\n계속영업당기순이익(손실)\n(11,384,237)\n(14,015,782)\n(34,710,537)\n중단영업당기순이익(손실)\n-\n-\n(3,228,841)\n당기순이익(손실)\n(11,384,237)\n(14,015,782)\n(37,939,378)\n당기총포괄손익(손실)\n(11,384,320)\n(14,125,465)\n(37,925,181)\n지배기업소유주지분\n(11,283,478)\n(13,630,959)\n(37,925,181)\n비지배기업소유주지분\n(100,842)\n(494,506)\n-\n계속영업기본주당이익(손실)\n(239)\n(307)\n(2,261)\n중단영업기본주당이익(손실)\n-\n-\n(210)\n계속영업희석주당이익(손실)\n(239)\n(307)\n(2,261)\n중단영업희석주당이익(손실)\n-\n-\n(210)\n연결에 포함된 회사수(개)\n8\n5\n1\n연결대상회사는 다음과 같습니다.\n연도\n제20기 반기(2019년)\n제19기(2018년)\n제18기(2017년)\n회사명\n(주)모제림(주)넥스트매치(주)엔씨엘바이오(주)메타랩스코스메틱(주)모릭랩스(주)메타약품METALABS HONGKONG LIMITEDMETA JAPAN\n(주)모제림(주)넥스트매치(주)엔씨엘바이오(주)메타랩스코스메틱(주)모릭랩스\nACREX CHINA INC.\n(2) 요약 별도재무정보\xa0\n(단위:천원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 목\n제20기 반기\n제19기(2018년)\n제18기(2017년)\n[유동자산]\n28,188,937\n26,774,402\n25,071,711\nㆍ매출채권및기타채권\n3,992,917\n2,074,177\n3,937,575\nㆍ재고자산\n3,025,406\n1,461,090\n8,038,867\nㆍ기타 유동자산\n21,170,614\n23,239,135\n13,095,269\n[비유동자산]\n78,800,565\n67,574,337\n21,420,296\nㆍ장기매출채권 및 기타채권\n-\n112,220\n122,008\nㆍ유형자산\n1,637,249\n1,118,336\n13,824,214\nㆍ무형자산\n17,432,046\n2,098,965\n33,973\nㆍ기타의 비유동자산\n59,731,270\n64,244,816\n7,440,101\n자산\xa0 총계\n106,989,502\n94,348,739\n46,492,007\n[유동부채]\n21,044,557\n24,605,922\n14,583,735\n[비유동부채]\n11,396,851\n473,222\n1,339,983\n부채\xa0 총계\n32,441,408\n25,079,144\n15,923,718\n[납입자본]\n26,154,493\n22,274,896\n15,110,923\n[기타자본구성요소]\n60,576,985\n152,737,297\n137,187,580\n[결손금]\n(12,183,384)\n(105,742,598)\n(121,730,213)\n자본\xa0 총계\n74,548,094\n69,269,595\n30,568,289\n종속ㆍ관계ㆍ공동기업\n원가법\n원가법\n원가법\n투자주식의 평가방법\n2019.01.01-06.30\n2018.01.01-12.31\n2017.01.01~12.31\n매출액\n10,681,356\n18,522,860\n27,205,729\n계속영업이익(손실)\n(2,353,188)\n(11,991,186)\n(15,564,604)\n계속영업당기순이익(손실)\n(12,664,423)\n(14,211,574)\n(34,788,494)\n중단영업당기순이익(손실)\n-\n2,580,846\n-\n당기순이익(손실)\n(12,664,423)\n(11,630,728)\n(34,788,494)\n당기총포괄손익(손실)\n(12,769,877)\n(12,218,471)\n(34,774,297)\n계속영업기본주당이익(손실)\n(268)\n(322)\n(2,266)\n중단영업기본주당이익(손실)\n-\n59\n-\n계속영업희석주당이익(손실)\n(268)\n(322)\n(2,266)\n중단영업희석주당이익(손실)\n-\n59\n-\n']"
